|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Processa Pharmaceuticals (NASDAQ: PCSA) through any online brokerage.
The latest price target for Processa Pharmaceuticals (NASDAQ: PCSA) was reported by Craig-Hallum on October 28, 2020. The analyst firm set a price target for 12.00 expecting PCSA to rise to within 12 months (a possible 71.43% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Processa Pharmaceuticals (NASDAQ: PCSA) is $7 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Processa Pharmaceuticals.
There is no upcoming split for Processa Pharmaceuticals.
Processa Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.